These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25984995)

  • 21. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
    Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
    J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities.
    Calzavara L; Ramuscak N; Burchell AN; Swantee C; Myers T; Ford P; Fearon M; Raymond S
    CMAJ; 2007 Jul; 177(3):257-61. PubMed ID: 17664449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
    Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
    J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A second type of magnitude effect: Reinforcer magnitude differentiates delay discounting between substance users and controls.
    Mellis AM; Woodford AE; Stein JS; Bickel WK
    J Exp Anal Behav; 2017 Jan; 107(1):151-160. PubMed ID: 28101922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance Use Patterns of HIV-Infected Russian Women with and Without Hepatitis C Virus Co-infection.
    Brown JL; DiClemente RJ; Sales JM; Rose ES; Safonova P; Levina OS; Belyakov N; Rassokhin VV
    AIDS Behav; 2016 Oct; 20(10):2398-2407. PubMed ID: 26995679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
    Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
    J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV and hepatitis C virus co-infection among men who have sex with men in Sydney, and associations with sexual and drug use practices.
    Lea T; Lee E; Mao L; de Wit J; Holt M
    Sex Health; 2013 Nov; 10(5):448-51. PubMed ID: 23849088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delay discounting, self-control, and substance use among adult drug court participants.
    Jones CG; Fearnley H; Panagiotopoulos B; Kemp RI
    Behav Pharmacol; 2015 Aug; 26(5):447-59. PubMed ID: 26110226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
    Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
    PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of HIV and HCV infection among drug users in China.
    Bao YP; Liu ZM
    Int J STD AIDS; 2009 Jun; 20(6):399-405. PubMed ID: 19451325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biased and less sensitive: A gamified approach to delay discounting in heroin addiction.
    Scherbaum S; Haber P; Morley K; Underhill D; Moustafa AA
    J Clin Exp Neuropsychol; 2018 Mar; 40(2):139-150. PubMed ID: 28485671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discounting preferences and response consistency as markers of functional ability in community-dwelling older adults.
    Lindbergh CA; Puente AN; Gray JC; MacKillop J; Miller LS
    J Clin Exp Neuropsychol; 2014; 36(10):1112-23. PubMed ID: 25486378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Survey of prevalence of HIV infection, syphilis and HCV infection and related risk behaviors among club drug users in Zhejiang, 2011].
    Pan X; Jiang J; He H; Chen L; Yang J; Zhang H; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Sep; 36(9):934-40. PubMed ID: 26814857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
    Lindenburg CE; Lambers FA; Urbanus AT; Schinkel J; Jansen PL; Krol A; Casteelen G; van Santen G; van den Berg CH; Coutinho RA; Prins M; Weegink CJ
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):23-31. PubMed ID: 21042221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.